[1]
K. C. S, S. N, S. Akbar, K. R, and A. S, “PHYSICIAN-REPORTED EXPERIENCE WITH DAPAGLIFLOZIN IN TYPE 2 DIABETES: EVIDENCE FROM SOUTHERN INDIA”, Int J Life Sci Pharm Res, vol. 16, no. 1, pp. 28–33, Mar. 2026.